ETON
Eton Pharmaceuticals Inc
57.10$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | -1,879.7% | -57,297.4% | -21.6% | 22.7% | 21.5% | 2.5% | 13.2% | |
| – | – | 46.6% | 1,669.2% | 2.1% | 8.3% | 2.8% | 2.9% | 5.1% | |
| – | – | 196.9% | 6,605.1% | 15.5% | 19.8% | 9.9% | 8.1% | 6.9% | |
| – | – | 196.9% | 9,846.2% | 13.0% | 19.8% | – | – | – | |
| – | – | -214.5% | 2,594.9% | -28.4% | 36.1% | 11.2% | -1.8% | -1.1% | |
| – | – | 192.5% | 128.2% | 14.9% | 13.1% | 2.4% | 0.1% | 0.4% | |
| – | – | -192.5% | -128.2% | -11.7% | -13.1% | -2.4% | -102.6% | -0.4% | |
| – | – | 47.2% | 74,741.0% | – | 1.2% | – | – | – | |
| – | – | 495.3% | 6,348.7% | -0.7% | -1.8% | -3.7% | 61.9% | 0.0% | |
| – | – | 542.5% | 81,089.7% | 1.8% | -0.6% | -3.0% | 83.5% | 1.0% | |
| – | – | -1,529.6% | 23,664.1% | -31.6% | 8.9% | 16.1% | -16.5% | 13.8% | |
| – | – | -2,072.2% | -57,425.6% | -36.6% | 9.6% | 19.1% | 2.4% | 12.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.